+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Radiodermatitis Drug"

From
Radiodermatitis- - Pipeline Insight, 2024 - Product Thumbnail Image

Radiodermatitis- - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Radiodermatitis - Global Strategic Business Report - Product Thumbnail Image

Radiodermatitis - Global Strategic Business Report

  • Report
  • May 2024
  • 93 Pages
  • Global
From
From
From
Radiodermatitis- Epidemiology Forecast to 2032 - Product Thumbnail Image

Radiodermatitis- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Radiodermatitis - Pipeline Review, H1 2020 - Product Thumbnail Image

Radiodermatitis - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 57 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Radiodermatitis is a type of dermatological drug used to treat skin damage caused by radiation therapy. It is a topical cream or ointment that helps to reduce inflammation, itching, and pain associated with radiation-induced skin damage. It also helps to protect the skin from further damage and can help to reduce the risk of infection. Radiodermatitis drugs are typically used in combination with other treatments such as moisturizers and antibiotics. Radiodermatitis drugs are available in both prescription and over-the-counter forms. Common active ingredients in these drugs include corticosteroids, vitamin E, and aloe vera. These drugs are typically used for a short period of time and are not intended for long-term use. Some companies in the Radiodermatitis Drug market include GlaxoSmithKline, Pfizer, Merck, and Johnson & Johnson. Show Less Read more